FIELD: medicine.
SUBSTANCE: invention relates to method of treating human patient with cancer by means of combined therapy with application of ET-743 in doses smaller than 1200 mcg/ m2 per day and platinum anti-tumour agent - carboplatin in doses from 200 to 400 mcg/ m2 per day. Application of ET-743 in combination with carboplatin in the same range of dosage as it is used in case of individual carboplatin introduction results in overcoming of resistance to platinum anti-tumour compound without increase of toxicity of each medication.
EFFECT: invention also relates to medical set which includes combination of ET-743 and carboplatin in said dosages, pharmaceutically acceptable carrier and treatment scheme instruction.
29 cl, 10 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION AND UTILIZATION OF ET743 FOR MALIGNANT TUMOR TREATMENT | 2000 |
|
RU2266734C2 |
COMBINED CHEMOTHERAPY | 2001 |
|
RU2284818C2 |
COMBINED CHEMOTHERAPY | 2006 |
|
RU2429838C2 |
COMBINED CHEMOTHERAPY | 2010 |
|
RU2587013C2 |
PEGYLATED LIPOSOMAL DOXORUBICINUM IN COMBINATION WITH ECTEINESCIDIN 743 | 2005 |
|
RU2359700C2 |
IMPROVED SCHEME OF USING ANTITUMOR COMPOUND IN CANCER THERAPY | 2002 |
|
RU2306933C2 |
TREATMENT OF MALIGNANT TUMOR WITH APLIDINE | 2000 |
|
RU2261104C2 |
METHOD FOR ENHANCING EFFECTIVENESS OF ANTITUMOR AGENTS | 2000 |
|
RU2271829C2 |
COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID | 2011 |
|
RU2605335C2 |
COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2018 |
|
RU2757373C2 |
Authors
Dates
2010-06-10—Published
2004-06-01—Filed